{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:13:13Z","timestamp":1771564393550,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3165,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:sec>\n            <jats:title\/>\n          <\/jats:sec>","DOI":"10.1002\/hep.21514","type":"journal-article","created":{"date-parts":[[2006,12,22]],"date-time":"2006-12-22T22:47:35Z","timestamp":1166827655000},"page":"6-8","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Porphyria cutanea tarda: A possible role for ascorbic acid"],"prefix":"10.1097","volume":"45","author":[{"given":"Karl E.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-3-20241202","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1013746828074","article-title":"Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.","volume":"47","author":"Egger","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R4-3-20241202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-0960.1988.tb01216.x","article-title":"Plasma ferritin levels as a guide to the treatment of porphyria cutanea tarda by venesection.","volume":"29","author":"Ratnaike","year":"1988","journal-title":"Australas J Dermatol"},{"key":"R5-3-20241202","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM196008252630807","article-title":"Cutaneous porphyria in Turkey.","volume":"263","author":"Schmid","year":"1960","journal-title":"N Engl J Med"},{"key":"R6-3-20241202","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1073\/pnas.98.1.259","article-title":"A mouse model of familial porphyria cutanea tarda.","volume":"98","author":"Phillips","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-3-20241202","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/bj3300149","article-title":"Uroporphyria produced in mice by iron and 5aminolaevulinic acid does not occur in Cyp1a2() null mutant mice.","volume":"330","author":"Sinclair","year":"1998","journal-title":"Biochem J"},{"key":"R8-3-20241202","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/abbi.2000.2124","article-title":"Relative roles of CYP2E1 and CYP1A2 in mouse uroporphyria caused by acetone.","volume":"384","author":"Sinclair","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"R9-3-20241202","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/taap.1999.8832","article-title":"CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron.","volume":"162","author":"Sinclair","year":"2000","journal-title":"Toxicol Appl Pharmacol"},{"key":"R10-3-20241202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/taap.2001.9167","article-title":"Protection of the Cyp1A2() null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8tetrachlorodibenzopdioxin.","volume":"173","author":"Smith","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"R11-3-20241202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0741-8329(03)00127-7","article-title":"Iron as a comorbid factor in nonhemochromatotic liver disease.","volume":"30","author":"Bonkovsky","year":"2003","journal-title":"Alcohol"},{"key":"R13-3-20241202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(85)90287-9","article-title":"Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.","volume":"2","author":"Elder","year":"1985","journal-title":"Lancet"},{"key":"R14-3-20241202","first-page":"185","article-title":"Ascorbate status of patients with porphyria cutanea tarda symptomatica and its effect on porphyrin metabolism.","volume":"40","author":"Percy","year":"1975","journal-title":"S Afr J Med Sci"},{"key":"R15-3-20241202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0022-2143(97)90096-2","article-title":"Ascorbic acid deficiency in porphyria cutanea tarda.","volume":"130","author":"Sinclair","year":"1997","journal-title":"J Lab Clin Med"},{"key":"R16-3-20241202","first-page":"861","article-title":"Circulating pro and antioxidant factors in iron and porphyrin metabolism disorders.","volume":"31","author":"Rocchi","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"R17-3-20241202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hep.21474","article-title":"Effect of iron and ascorbate on uroporphyria in ascorbaterequiring mice as a model for porphyria cutanea tarda.","volume":"45","author":"Gorman","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R18-3-20241202","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1006\/abbi.1993.1376","article-title":"Ascorbic acid inhibition of cytochrome P450catalyzed uroporphyrin accumulation.","volume":"304","author":"Sinclair","year":"1993","journal-title":"Arch Biochem Biophys"},{"key":"R19-3-20241202","first-page":"565","article-title":"Ascorbic acid inhibits chemically induced uroporphyria in ascorbaterequiring rats.","volume":"22","author":"Sinclair","year":"1995","journal-title":"HEPATOLOGY"},{"key":"R20-3-20241202","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2133.1972.tb00316.x","article-title":"Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria.","volume":"87","author":"Taljaard","year":"1972","journal-title":"Br J Dermatol"},{"key":"R21-3-20241202","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.1984.tb06632.x","article-title":"Lowdose oral chloroquine in the treatment of porphyria cutanea tarda.","volume":"3","author":"Ashton","year":"1984","journal-title":"Br J Dermatol"},{"key":"R22-3-20241202","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1067\/mlc.2000.111024","article-title":"Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda.","volume":"136","author":"Bulaj","year":"2000","journal-title":"J Lab Clin Med"},{"key":"R23-3-20241202","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.1840160603","article-title":"HepatitisC virus and porphyria cutanea tardaevidence of a strong association.","volume":"16","author":"Fargion","year":"1992","journal-title":"HEPATOLOGY"},{"issue":"Suppl 1","key":"R24-3-20241202","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.21056","article-title":"An editors lookback.","volume":"43","author":"Berk","year":"2006","journal-title":"HEPATOLOGY"},{"key":"RU25-3-20241202","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s004390000415","article-title":"Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda.","volume":"107","author":"Christiansen","year":"2000","journal-title":"Hum Genet"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21514","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200701000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:06:32Z","timestamp":1733155592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200701000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21514","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}